Last reviewed · How we verify
Oral strogen
At a glance
| Generic name | Oral strogen |
|---|---|
| Also known as | estradiol till 12 gestational weeks, estradiol till 6 gestational weeks |
| Sponsor | Parc de Salut Mar |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
- Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair (NA)
- Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers (NA)
- Bovine Colostrum Efficacy for the Treatment of Chronic Prostatitis Symptoms. (PHASE4)
- Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial (NA)
- Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair (NA)
- Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair (NA)
- Luteal Phase Support During Frozen Embryo Transfer Cycle (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral strogen CI brief — competitive landscape report
- Oral strogen updates RSS · CI watch RSS
- Parc de Salut Mar portfolio CI